首页|原发性肝癌切除术后患者应用肝动脉化疗栓塞术治疗的效果及其对肝功能、肿瘤标志物水平及预后的影响

原发性肝癌切除术后患者应用肝动脉化疗栓塞术治疗的效果及其对肝功能、肿瘤标志物水平及预后的影响

扫码查看
目的 探究原发性肝癌切除术后患者应用肝动脉化疗栓塞术治疗的效果.方法 选取我科 124 例原发性肝癌切除术后患者作为研究对象,灌注组 62 例采取肝动脉化疗灌注术,栓塞组 62 例采取肝动脉化疗栓塞术,对比两组患者疾病控制率、肝功能、肿瘤标志物水平、中位无进展生存期、总生存率及不良反应发生率.结果 化疗后,栓塞组疾病控制率高于灌注组(P<0.05).两组肝功能指标水平均降低(P<0.05),栓塞组高于灌注组(P<0.05).两组肿瘤标志物水平均降低(P<0.05),且栓塞组更低(P<0.05).栓塞组中位无进展生存期高于灌注组(P<0.05),栓塞组总生存率高于灌注组(P<0.05).两组不良反应发生率差异无统计学意义(P>0.05).结论 肝动脉化疗栓塞术用于治疗原发性肝癌切除术后患者疗效确切,能够提高疾病控制率,延长生存时间,且对肝功能影响较小,并降低肿瘤标志物水平.
Effect of Hepatic Arterial Chemoembolization on Liver Function,Tumor Marker Level and Prognosis in Patients with Primary Hepatocellular Carcinoma after Resection
Objective To investigate the effect of hepatic arterial chemoembolization in patients with primary hepatocellular carcinoma after resection.Methods A total of 124 patients after primary liver cancer resection were selected as the study objects.62 patients in the perfusion group received hepatic artery chemoembolization,and 62 patients in the embolization group received hepatic artery chemoembolization.Disease control rate,liver function,tumor marker level,median progression-free survival,overall survival and incidence of adverse reactions were compared between the two groups.Results After chemotherapy,the disease control rate of embolization group was higher than that of perfusion group(P<0.05).After chemotherapy,the levels of liver function indexes in both groups were decreased(P<0.05),and those in embolization group were higher than those in perfusion group(P<0.05).After treatment,tumor marker levels were decreased in both groups(P<0.05),and were lower in embolization group(P<0.05).After treatment,the median progression-free survival in embolization group was higher than that in perfusion group(P<0.05),and the overall survival rate in embolization group was higher than that in perfusion group(P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion Hepatic arterial chemoembolization is effective in the treatment of patients with primary hepatocellular carcinoma after resection.It can improve the disease control rate,prolong the survival time,have little effect on liver function,and reduce the level of tumor markers.

Primary liver cancerChemoembolizationLiver functionTumor markersprognosis

何淑赛、陈旭、罗磊、黄运德

展开 >

郑州大学附属郑州中心医院肝胆胰微创外科,河南 郑州 450000

原发性肝癌 化疗栓塞术 肝功能 肿瘤标志物 预后

2024

哈尔滨医药
哈尔滨市医学会

哈尔滨医药

影响因子:0.697
ISSN:1001-8131
年,卷(期):2024.44(6)